Pro Chart

Cellebrite DI Ltd.

NasdaqGS: CLBT · Real-Time Price · USD
15.34
-0.69 (-4.30%)
At close: Aug 12, 2026, 2:37 PM

Cellebrite DI Ltd. (CLBT) Stock Price, Analysis & Data

-4.30%
Bid11.59
Market Cap3.83B
Revenue (ttm)496.43M
Net Income (ttm)71.35M
Beta1.18
EPS (ttm)0.28
PE Ratio (ttm)54.79
Forward PE23.21
P/B (ttm)7.41
P/S (ttm)7.71
Earnings DateAug 11, 2022
Ask19.72
Volume868,489
Avg. Volume (20D)1,955,030
Open15.79
Previous Close16.03
Day's Range15.27 - 16.10
52-Week Range11.02 - 19.98
AnalystStrong Buy
Price Target21 (36.90%)
Dividendsn/a
Ex-Dividend Daten/a

About CLBT

Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, s...

Sector Technology
IPO Date Nov 6, 2020
Employees 1,285
Stock Exchange NasdaqGS
Ticker Symbol CLBT
Full Company Profile

Financial Performance

In 2025, Cellebrite DI's revenue was 475.68M, an increase of 18.56% compared to the previous year's 401.2M. Earnings were 78.33M, a decrease of -127.68%.

Financial Statements

Analyst Forecast

According to 7 analyst ratings, the average rating for CLBT stock is "Strong Buy". The 12-month stock price forecast is 21, which is upside of 36.9% from the latest price.

Stock Forecasts

Earnings Surprise

Cellebrite DI has released their quarterly earnings on May 14, 2026:
  • Revenue of $128.3M misses estimates by $0, with 19.30% YoY growth.
  • EPS of 0.12 exceeds estimates by 0.02, with 20.00% YoY growth.
  • Cellebrite DI Ltd. is scheduled to release its earnings on Aug 11, 2022, before market opens.
    Analysts project revenue of ... Upgrade
    Page 1 of 2